‌

US Patent 10660912 Combination therapy for cancer

Patent 10660912 was granted and assigned to NuCana on May, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

NuCana

Current Assignee

NuCana

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106609120

Date of Patent

May 26, 2020

Patent Application Number

157532370

Date Filed

October 5, 2015

Patent Citations

‌

US Patent 10005810 Process for preparing nucleoside prodrugs

Patent Citations Received

‌

US Patent 11629164 Gemcitabine prodrugs

‌

US Patent 11414452 Synthesis of phosphate derivatives

Patent Primary Examiner

‌

Lawrence E Crane

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10660912 Combination therapy for cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API